Recruiting Type 2 Diabetes Studies in Durham
About Type 2 Diabetes Clinical Trials in Durham
Type 2 diabetes is a chronic metabolic condition affecting over 37 million Americans, characterized by insulin resistance and progressive loss of beta-cell function. While metformin remains the first-line treatment, the treatment landscape has expanded dramatically with GLP-1 receptor agonists (semaglutide, tirzepatide), SGLT2 inhibitors (empagliflozin, dapagliflozin), and dual GIP/GLP-1 agonists showing both glycemic and cardiovascular benefits. Clinical trials are now exploring triple-hormone agonists, oral GLP-1 formulations, islet cell regeneration therapies, and precision medicine approaches that tailor treatment to individual metabolic profiles. Patients with uncontrolled HbA1c on current medications, those with diabetic complications, or newly diagnosed patients may qualify for enrollment.
There are currently 1 type 2 diabetes clinical trials recruiting participants in Durham, NC. These studies are seeking a combined 60 participants. Research is being sponsored by Zhuhai Rui-Inno Pharmaceutical Technology Co., Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Type 2 Diabetes Clinical Trials in Durham — FAQ
Are there type 2 diabetes clinical trials in Durham?
Yes, there are 1 type 2 diabetes clinical trials currently recruiting in Durham, NC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Durham?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Durham research site will contact you about next steps.
Are clinical trials in Durham free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Durham studies also compensate for your time and travel.
What type 2 diabetes treatments are being tested?
The 1 active trials in Durham are testing new therapies including novel drugs, biologics, and treatment approaches for type 2 diabetes.
Data updated July 13, 2026 from ClinicalTrials.gov